iQone Healthcare Switzerland is an independent Swiss specialty pharma company focussing on the commercialisation of biosimilars, orphan drugs and oncology products. As a Swiss company founded by leading members of the pharmaceutical industry, we have created an agile model to accelerate the transition to biosimilars. Today, the choice of biosimilars is tangible proof of physicians' commitment to the public interest. And prescribing the best available treatment at the best price is an issue of social responsibility. Be the actor of this paradigm shift together with us!